Back
Harmony Biosciences Holdings, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
69
HRMY
Harmony Biosciences Holdings, Inc.
Last Price:
$37.88
Seasonality Move:
-9.03%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$65.75
Seasonality Move:
10.04%
Buy
69
Harmony Biosciences Holdings, Inc. (HRMY)
is a Buy
Is Harmony Biosciences Holdings, Inc. a Buy, Sell or Hold?
-
The current Harmony Biosciences Holdings, Inc. [HRMY] share price is $38.13. The Score for HRMY is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
HRMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $68.77. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings, Inc.'s stock price today?
-
The Harmony Biosciences Holdings, Inc. share price today is $38.13The current trend is moderately bullish and HRMY is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $68.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 57.29 | Buy |
| Chaikin Money Flow: | -113784 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.67 - 39.41) | Buy |
| Bollinger Bands (100): | (28.95 - 37.57) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.4 | Sell |
| Relative Strength Index (14 RSI): | 38.64 | Sell |
| Chaikin Money Flow: | -309210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.06 - 84.9) | Sell |
| Bollinger Bands (100): | (47.41 - 89.71) | Buy |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.35 | Sell |
| 20-day SMA: | 38.24 | Sell |
| 50-day SMA: | 33.94 | Buy |
| 200-day SMA: | 33.15 | Buy |
| 8-day EMA: | 38.4 | Sell |
| 20-day EMA: | 37.7 | Buy |
| 50-day EMA: | 35.37 | Buy |
| 200-day EMA: | 33.7 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.35 | Sell |
| 20-day SMA: | 74.69 | Sell |
| 50-day SMA: | 79.58 | Sell |
| 200-day SMA: | 53.14 | Buy |
| 8-day EMA: | 70.55 | Sell |
| 20-day EMA: | 74.01 | Sell |
| 50-day EMA: | 75.82 | Sell |
| 200-day EMA: | 57.21 | Buy |
Harmony Biosciences Holdings, Inc. Earnings Growth & HRMY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.57 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Harmony Biosciences Holdings, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||